Immunologic and clinical evaluation of multiple sclerosis patients treated with corticosteroids and/or calf thymic hormones.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D000818:Animals; D002417:Cattle; D002478:Cells, Cultured; D005260:Female; D006801:Humans; D007376:Interleukin-2 / Q000096:biosynthesis; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000187:drug effects / Q000276:immunology*; D008297:Male; D009103:Multiple Sclerosis / Q000188:drug therapy / Q000276:immunology* / Q000503:physiopathology; D012397:Rosette Formation; D013601:T-Lymphocytes / Q000276:immunology; D013951:Thymus Hormones / Q000627:therapeutic use*
D000305:Adrenal Cortex Hormones; D007376:Interleukin-2; D013951:Thymus Hormones